Topic: Hypoparathyroidism new developments
Organised by: ECTS Rare bone diseases action group and ERN BOND
Chair: To be confirmed
Speaker: Dr. Maria Yavropoulou, LAIKO University Hospital, Athens, Greece
Date & Time: Thursday, 16 April 2026 from 16.00-17.00hrs CET
Format: Live Interactive Webinar. On-demand recording to be available for ECTS full tier members after the event

Registration

The live webinar is free and open to everyone with an interest in the field.

Register

Key learning objectives:

By the end of this session, participants will be able to:
• Evaluate new therapeutic approaches, including parathyroid hormone replacement strategies and their impact on biochemical control, quality of life, and long-term complications.
• Explain the therapeutic rationale and emerging clinical evidence for calcilytics (e.g., encaleret) in hypoparathyroidism management.
• Apply updated clinical evidence to optimize management, including individualized treatment targets, monitoring strategies, and risk mitigation for renal and skeletaL complications.

Agenda:

Introduction (3 min)
Presentation on “Hypoparathyroidism new developments” (35 min)
Live Q&A from the audience (20 min)
Conclusion and key messages (2 min)